Jerzy Windyga

18PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyAnimal protection (incl. pests and pathogens)Cardiology (incl. cardiovascular diseases)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 24, 2026
Concizumab in patients with hemophilia A or B without inhibitors: 56-week cut-off results of the phase 3 explorer8 study.

|Jul 17, 2025
Safety and Use of Eptacog Beta 225 µg/kg in Patients With Haemophilia A or B With Inhibitors.

Manuel Carcao, Cédric Hermans, Adam Giermasz

|Jul 20, 2024
Disease and treatment burden of patients with haemophilia entering the explorer6 non-interventional study.

Jerzy Windyga, Shashikant Apte, Melissa Frei-Jones

|Feb 06, 2024
Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single-arm, open-label study.

Christian Pfrepper, Paolo Radossi, Jerzy Windyga

|Apr 18, 2023
Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations.

Imre Bodó, Ismail Amine, Ana Boban

|Feb 21, 2023
Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe.

Cedric Hermans, Jan Astermark, Manuela Carvalho

Pageof 3

Frequent Collaborators

5 joint publications

Johnny N Mahlangu

2 joint publications

Craig Kessler

2 joint publications

Kaan Kavakli

2 joint publications

Pratima Chowdary